Evidence map›Paper›PMID 26490967›Full record

ArticleInflammation2016

Fc Gamma Receptor IIA (CD32A) R131 Polymorphism as a Marker of Genetic Susceptibility to Sepsis.

Jaqueline Beppler, Patrícia Koehler-Santos, Gabriela Pasqualim, Ursula Matte, Clarice Sampaio Alho, Fernando Suparregui Dias, Thayne Woycinck Kowalski, Irineu Tadeu Velasco, Renato C Monteiro, Fabiano Pinheiro da Silva

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  10. Signaling by Antibodies: Recent Progress.Annual review of immunology · 2017
    Review
  11. Article
  12. Review
  13. The role of genetics and antibodies in sepsis.Annals of translational medicine · 2016
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Jaqueline BepplerEmergency Medicine Department, University of Sao Paulo, Sao Paulo, Brazil.
Patrícia Koehler-SantosProteins and Molecular Analysis Unit, Experimental Research Center, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Gabriela PasqualimGene Therapy Unit, Experimental Research Center, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Ursula MatteGene Therapy Unit, Experimental Research Center, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Clarice Sampaio AlhoSchool of Biosciences and Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.
Fernando Suparregui DiasSchool of Biosciences and Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.
Thayne Woycinck KowalskiPostgraduate Program in Genetics and Molecular Biology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Irineu Tadeu VelascoEmergency Medicine Department, University of Sao Paulo, Sao Paulo, Brazil.
Renato C MonteiroInserm Unit 1149 and ERL Cnrs 8252, Center for Research on Inflammation, University Paris Diderot, Paris, France.
Fabiano Pinheiro da SilvaEmergency Medicine Department, University of Sao Paulo, Sao Paulo, Brazil. pinheirofabiano@hotmail.com.
Hospital de Clínicas de Porto Alegre · BRUniversidade de São Paulo · BRUniversidade Federal do Rio Grande do Sul · BRHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRHospital São Lucas da PUCRS · BRPontifícia Universidade Católica do Rio Grande do Sul · BRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis is a devastating disease that can affect humans at any time between neonates and the elderly and is associated with mortality rates that range from 30 to 80%. Despite intensive efforts, its treatment has remained the same over the last few decades. Fc receptors regulate multiple immune responses and have been investigated in diverse complex diseases. FcγRIIA (CD32A) is an immunoreceptor, tyrosine-based activation motif-bearing receptor that binds immunoglobulin G and C-reactive protein, important opsonins in host defense. We conducted a study of 702 patients (184 healthy individuals, 171 non-infected critically ill patients, and 347 sepsis patients) to investigate if genetic polymorphisms in the CD32A coding region affect the risk of septic shock. All individuals were genotyped for a variant at position 131 of the FcγRIIA gene. We found that allele G, associated with the R131 genotype, was significantly more frequent in septic patients than in the other groups (p = 0.05). Our data indicate that FcγRIIA genotyping can be used as a marker of genetic susceptibility to sepsis.

Indexed as

Critical IllnessFemaleGenetic MarkersGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedPolymorphism, Single NucleotideReceptors, IgGSepsisFc gamma receptor IIAFCGR2A protein, humanGenetic MarkersReceptors, IgGbiomarkerscritical caregenetic susceptibilityinfectioninflammation

Identifiers

PMID26490967
OpenAlexW2192123377

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.